Clinical Scorecard: Reevaluating Infection in Pediatric Atopic Dermatitis: From Microbial Imbalance to Targeted Prevention Strategies

At a Glance

Key Highlights

• Infection in pediatric AD is a dynamic, multifactorial process.
• AD increases the difficulty of clearing infections like molluscum contagiosum.
• Genetic factors influence severe phenotypes of AD and associated infections.
• Comorbid conditions like ASD interact with AD, affecting immune responses.
• Emerging therapies include dupilumab and JAK inhibitors for microbiome modification.

Guideline-Based Recommendations

Diagnosis

• Early recognition of complications in pediatric AD is crucial.

Management

• Focus on controlling underlying AD rather than treating infections individually.
• Consider antibiotic selection with MRSA coverage and antiviral therapy for eczema herpeticum.

Monitoring & Follow-up

• Children with AD require closer follow-up and realistic parent education regarding treatment outcomes.

Risks

• Increased susceptibility to infections due to immune dysregulation and microbiome dysbiosis.

Patient & Prescribing Data

Children with atopic dermatitis and associated infections.

AD children may require more treatment sessions for infections compared to those without AD.

Clinical Best Practices

• Integrate skin barrier measurements, immune profiling, and microbiome data in clinical assessments.
• Utilize emerging approaches such as endolysins and bacteriotherapy for managing infections.

Related Resources & Content

• Research Topic on Infection Dynamics in Pediatric Atopic Dermatitis